Daiichi Sankyo Europe's Statement Regarding Esperion Therapeutics' Complaint $DownloadTitle.getData()
Industry Veteran, Dr. Mark Rutstein, Joins Daiichi Sankyo to Lead Global Oncology Clinical Development Program View Resource
Daiichi Sankyo, Inc. has taken measures to contribute to the overall effort to limit the spread of the virus that causes COVID-19. $DownloadTitle.getData()
Daiichi Sankyo Co., Ltd - Global